Skip to search formSkip to main contentSkip to account menu

AHSG gene

Known as: FETUA, HSGA, FETUIN A 
This gene is involved in bone mineralization.
National Institutes of Health

Related topics

Related topics

4 relations
AHSG protein, humanPhagocytosis Inductionalpha-2-HS-Glycoproteinskeletal development

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study
Background— Elevated circulating levels of fetuin-A in blood have been associated with increased risk of cardiovascular disease… 
Highly Cited
2009
Highly Cited
2009
Glycoproteomic Analysis of Human Lung Adenocarcinomas Using Glycoarrays and Tandem Mass Spectrometry: Differential Expression and Glycosylation Patterns of Vimentin and Fetuin A Isoforms
Human lung cancer is a major cause of cancer mortality worldwide. Advances in pathophysiologic understanding and novel biomarkers… 
Highly Cited
2008
Highly Cited
2008
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
BACKGROUND Type-2 diabetes and diabetic kidney disease have additive effects on cardiovascular risk. Furthermore, the degree of… 
Highly Cited
2007
Highly Cited
2007
Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice.
BACKGROUND Chronic kidney disease (CKD) is associated with vascular and tissue calcification. The extent of vascular… 
Highly Cited
2006
Highly Cited
2006
Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.
OBJECTIVE The alpha(2)-Heremans-Schmid glycoprotein (AHSG; fetuin-A in animals) impairs insulin signaling in vitro and in rodents… 
Highly Cited
2005
Highly Cited
2005
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
BACKGROUND Vascular calcification is common among end-stage renal disease (ESRD) patients and a central characteristic of the… 
Highly Cited
2003
Highly Cited
2003
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study
Highly Cited
2002
Highly Cited
2002
Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes.
OBJECTIVE Human fetuin/alpha(2)-HS-glycoprotein (AHSG) is a 49 kDa serum and tissue protein which is a natural inhibitor of… 
Highly Cited
2001
Highly Cited
2001
Systemic inhibition of spontaneous calcification by the serum protein α2-HS glycoprotein/fetuin
The extracellular fluid is a metastable system with regard to calcium and phosphate ions. Active inhibitors of calcification must… 
Highly Cited
1993
Highly Cited
1993
Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level.
The insulin-dependent tyrosine kinase activity (TKA) of the insulin receptor (IR) plays an essential role in insulin signaling… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License